A recent discovery by Van Andel Research Institute scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma - the most common and most aggressive malignant brain tumor in humans.
Discovery predicts patient sensitivity to important drug target in deadly brain cancer
- EurekAlert
- 6. 2 2012 (06:00)